IKIrina Al'Bertovna Karpova

Irina Al'Bertovna Karpova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Irina Al'Bertovna Karpova has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of inclusion of dietary fibers in the composition of the diet in obesity

    by Albert А. Kurmangulov, Elena F. Dorodneva, Irina A. Troshina, Yulianna A. Petrova, Tatyana I. Golubeva

    Background. In recent years, clinical work, discovered a correlation between the violations of quantitative and/or qualitative composition of the intestinal microbiota and the development of various dysmetabolic disorders, including obesity. Aims. To evaluate the effect of the additional inclusion in the diet program of foods with a high content of dietary fibers and microbiotics on anthropometric indicators of obesity. Materials and methods. The dynamic 6-month observation study included 50 people with 23 degrees of obesity (BMI35 kg/m2) according to WHO criteria, divided depending on the method of exposure (the traditional scheme of rational diet/or additionally enriched diet with fiber) into two comparable groups. Among the methods of the study were allocated anthropometry, the actual nutritional analysis and chromatographic study of short-chain fatty acids in the feces. Results. Analysis of anthropometric data (body weight, BMI, waist circumference) using the Wilcoxon test showed a more pronounced dynamics of basic anthropometric data in the group with additional enrichment diet dietary fiber (p0.01). The data of chromatographic studies showed more significant changes in the total concentration of short chain fatty acids (p0.01) and in their profile (p0.05) in the group with additional enrichment diet dietary fiber. Clinically normalization of symbiotic digestion in the intestine in the group with additional enrichment diet dietary fiber was confirmed by reducing the frequency of presented complaints, for flatulence and flatulence from 38.3% to 13.7% (p0.05), abdominal discomfort from 63.4% to 25.5% (p0.05), constipation from 44.5% to 13.8% (p0.05), rumbling in the abdomen on palpation from 50.4% to 18.8% (p0.05). Conclusions. Complex effect of dietary fiber within the food products of functional purpose on the processes and symbiotic digestion in the gastrointestinal tract leads to improved clinical and metabolic (normalization of functional activity of the intestinal microbiota) and anthropometric parameters (lower values of body weight, waist circumference), which predetermines the possibility of using dietary fiber in programmes for the treatment and prevention of obesity.


  • Open Access

    Effects of inclusion of dietary fibers in the composition of the diet in obesity

    by Albert А Kurmangulov, Elena F Dorodneva, Irina A Troshina, Yulianna A Petrova, Tatyana I Golubeva, Петрова Юлианна Алексеевна

    BACKGROUND. In recent years, clinical work, discovered a correlation between the violations of quantitative and/or qualitative composition of the intestinal microbiota and the development of various dysmetabolic disorders, including obesity. AIMS. To evaluate the effect of the additional inclusion in the diet program of foods with a high content of dietary fibers and microbiotics on anthropometric indicators of obesity. MATERIALS AND METHODS. The dynamic 6-month observation study included 50 people with 2–3 degrees of obesity (BMI≥35 kg/m2) according to WHO criteria, divided depending on the method of exposure (the traditional scheme of rational diet/or additionally enriched diet with fiber) into two comparable groups. Among the methods of the study were allocated anthropometry, the actual nutritional analysis and chromatographic study of short-chain fatty acids in the feces. RESULTS. Analysis of anthropometric data (body weight, BMI, waist circumference) using the Wilcoxon test showed a more pronounced dynamics of basic anthropometric data in the group with additional enrichment diet dietary fiber (p<0.01). The data of chromatographic studies showed more significant changes in the total concentration of short chain fatty acids (p<0.01) and in their profile (p<0.05) in the group with additional enrichment diet dietary fiber. Clinically normalization of symbiotic digestion in the intestine in the group with additional enrichment diet dietary fiber was confirmed by reducing the frequency of presented complaints, for flatulence and flatulence from 38.3% to 13.7% (p<0.05), abdominal discomfort from 63.4% to 25.5% (p<0.05), constipation from 44.5% to 13.8% (p<0.05), rumbling in the abdomen on palpation from 50.4% to 18.8% (p<0.05). CONCLUSIONS. Complex effect of dietary fiber within the food products of functional purpose on the processes and symbiotic digestion in the gastrointestinal tract leads to improved clinical and metabolic (normalization of functional activity of the intestinal microbiota) and anthropometric parameters (lower values of body weight, waist circumference), which predetermines the possibility of using dietary fiber in programmes for the treatment and prevention of obesity.

  • Open Access

    Metabolic disorders in adipocytokine imbalance and gestational complications

    by Natalya B. Chabanova, Sergey I. Mataev, Tatiana N. Vasilkova, Irina A. Troshina

    Adipose tissue as an endocrine organ synthesizes a large number of biologically active substances, adipocytokines, which have both local and systemic effects influencing the vascular wall, tissue sensitivity to insulin, glucose metabolism, and systemic inflammation. The data obtained from clinical and experimental studies demonstrate the close relationship between the imbalance of adipocytokines and pregnancy complications such as insulin resistance, gestational diabetes, and preeclampsia. In this connection, close attention of obstetrician-gynecologists and endocrinologists is focused on etiopathogenic aspects of the formation of gestational complications with metabolic disorders caused by an imbalance of adipocytokines with maternal obesity and to the search for markers of these disorders. The review presents the current literature data on adipose tissue hormones and their influence on the course of a gestational process.


  • Open Access

    Growth hormone deficiency and metabolic disorders after radiotherapy and chemotherapy of malignant tumors of the posterior cranial fossa

    by Tatiana Y. Tselovalnikova, Maria G. Pavlova, Alexey V. Zilov, Alla E. Yudina, Nadezhda A. Mazerkina, Olga G. Zheludkova, Evgenia Y. Kotlyarevskaya, Irina A. Arefyeva, Andrey N. Gerasimov, Olga A. Medvedeva

    Endocrine disorders are common in patients after treatment for brain tumors in childhood. Growth hormone (GH) deficiency is the most common consequence of cranial irradiation. Objective — to evaluate the prevalence of GH deficieny and metabolic disorders in patients after treatment for malignant tumors of the posterior cranial fossa (MT PCF) in childhood. Material and methods. In this study 40 patients (21 men, 19 women) who had undergone treatment for MT PCF were assessed. Patients underwent surgery, chemotherapy and craniospinal irradiation (CSI) in a dose of 34.9±1.6 Gy with a boost to the PCF 51.3±9.2 Gy. Age at the time of the survey — 19.8±3.05 years; age at the time of treatment — 10.9±3.4 years; follow-up — 7.2±4.2 years. Patient’s anthropometric and laboratory parameters were measured, GH failure was diagnosed by two tests – insulin tolerance test (ITT) and glucagon stimulation test (GST). Results. According to ITT GH deficiency was observed in 82.1% and according to GST in 60.0% of patients. When comparing two tests GST showed 100% specificity, but lower sensitivity (72.2%). Manifestation of GH deficiency depends on the age at the time of treatment (p=0.002). There is significant correlation between age at the time of treatment and SDS of final height (r=0.632; p<0.001). We found a significant correlation between age at the time of treatment and BMI (r=–0,327; p=0.04). Dyslipidemia occurred in 50% of cases. Insulin resistance was recorded in 16.7% of patients. We found significant correlation between the HOMA-IR and BMI (r=0.336; p=0.034). Conclusions. In patients after treatment for MT PCF in childhood GH deficiency and metabolic disorders is highly prevalent. This group of patients should be monitored by endocrinologist for timely detection and treatment of GH deficiency and metabolic complications.


  • Open Access

    Phenotypic and genetic characteristics of patients with type 2 diabetes with different responses to metformin therapy in Novosibirsk region

    by Irina A. Bondar, Olesya Y. Shabelnikova, Ekaterina A. Sokolova, Olga V. Pyankova, Maksim L. Filipenko

    Aim: The purpose of this study was to examine the phenotypic and genetic characteristics of patients with type 2 diabetes mellitus (T2DM) with different responses to treatment with metformin (MF) in the Novosibirsk region. Materials and methods: We examined 460 patients with T2DM in the Novosibirsk region. Patients were divided into groups according to their HbA1c level: patients who achieved the target HbA1c level during MF therapy (n = 209) and those who did not reach the target HbA1c level (n=251). Genotyping of ATM (rs11212617) was performed using polymerase chain reaction by TaqMan. Results: Patients who achieved the target HbA1c level during MF treatment (good response) were older (61. 1±9. 1 years vs. 57. 4±8. 4 years, p=0. 001), had later onset of diabetes (54. 6 ± 10. 1 years vs. 49. 2±8. 5 years, p = 0. 0001) and shorter duration of diabetes (6. 5±5. 9 years vs. 8. 2±6. 1 years, p=0. 03) compared with those who did not achieve the target HbA1c level. There was no statistically significant association between ATM rs11212617 and achieving the target HbA1c level among all patients [odds ratio (OR)=0. 94, 95% confidence interval = (0. 73–1. 23), p=0. 67] or those with MF monotherapy [OR=0. 90, (0. 65–1. 25), p=0. 54] or combination therapy [OR=1. 02, (0. 72–1. 43), p=0. 92]. There was an effect of age on response to MF therapy in all three groups (all patients: p=0. 001, MF monotherapy group: p=0. 04, combination therapy group: p=0. 0009). In the MF monotherapy group, low dose MF was associated with a good response (p=0. 03), and in the combination therapy group, males were more likely to have a good response (p=0. 003). Patients with genotype C/C or A/C for ATM (rs11212617) compared with those with genotype A/A were more likely to have high levels of triglycerides [2. 33 (1. 52–4. 2) mmol/l, 2. 09 (1. 35–3. 0) mmol/l and 1. 99 (1. 49–3. 21) mmol/l, respectively, p=0. 001], coronary heart disease (CHD) (13. 4%, 13. 4% and 9. 6%, respectively, p=0. 009) and myocardial infarction (7. 8%, 3. 2% and 4. 0%, respectively, p=0. 001). Conclusion: Patients with T2DM who had a good response to MF therapy were older, more likely to be male and had a later onset of T2DM. Genotype C/C for ATM rs11212617 was associated with high triglycerides, CHD and myocardial infarction. ATM rs11212617 was not associated with response to MF therapy in the Novosibirsk region.


  • Open Access

    Adipokines and metabolic parameters in patients with type 2 diabetes mellitus in combination with gout

    by Andrey F. Verbovoy, Irina A. Tsanava, Nelli I. Verbovaya

    Aim. To study the impact of type 2 diabetes and its combination with gout on the level of adipokines, hormonal and metabolic parameters. Materials and methods. The study included 18 men with type 2 diabetes with a mean age 57,83 ± 1,67 years, and 21 subjects with a combination of type 2 diabetes and gout, whose average age was 57,57 ± 1,44 years. The controls were 40 healthy men: 20 subjects with an average age of 21,03 ± 0,15 years and 20 men with average age 51,31 ± 1,34 years. All patients had anthropometric measurements, evaluation of parameters of lipid and carbohydrate metabolism, uric acid, levels of adiponectin, leptin and resistin. Results. Patients of both groups had elevated concentrations of leptin, resistin and reduced level of adiponectin. Men with type 2 diabetes, and its combination with gout had increased levels of total cholesterol, triglycerides, glucose and insulin. Conclusion. In patients with type 2 diabetes, and its combination with gout are characterized by hyperleptinemia, hypererresistinemia, hypooadiponectinemia. Insulin resistance with compensatory hyperinsulinemia and atherogenic dyslipidemia was found in all patient groups.


  • Open Access

    The use of orthopaedic shoes in patients with diabetes at high risk of foot amputation and Charcot arthropathy

    by Anastasia Gennagyevna Demina, Vadim Borisovich Bregovskiy, Ирина Альбертовна Карпова

    Aim. To evaluate the use of orthopaedic shoes in patients with diabetes with foot ulcers and/or previous minor amputations or Charcot arthropathy (CA) and factors influencing this use.Patients and methods. One hundred twenty-one patients with diabetes (55 men and 66 women; 36 in the inactive stage of CA) were included. A questionnaire based on footwear was used to evaluate patients’ compliance. Daily activity and the severity of the foot deformities were recorded. Further, foot geometry and forefoot and midfoot circumferences were measured.Results. Fifty-eight patients did not use orthopaedic shoes. Users and non-users did not differ in terms of gender and type of diabetes. The causes of refusal included ill-fitting shoes (56%), ugly appearance (11%), traumatisation with shoes (11%), inability to walk (5%) and other causes (17%). The percentages of patients in each category of deformity severity were mild (41.2%), moderate (37%) and severe (54%. Frequency of refusal of CA vs non-CA patients: 72.2% and 43.5%; with severe deformities,70.8% vs 34%; with moderate deformities, 83.3% vs 57.2% (p 0.05 for all). In patients with CA, the only significant parameter was the difference in the circumference of the midfoot between the affected and non-affected foot; in CA users and non-users, this parameter was 1.93 ± 1.25 vs 0.70 ± 0.83 cm, respectively (р = 0.01).Conclusions. The high frequency of refusing to wear orthopaedic shoes is related to severe foot deformities and the inability to accommodate them in off-the-shelf footwear. Most of the patients used orthopaedic shoes for outdoor use, but the frequency of use was low. Shoe compliance did not depend on gender but increased with ageing, low levels of daily activity and in patients with severe deformities. Patients with CA are characterised with extremely low compliance. In this group, foot parameters and other objective parameters did not rely on footwear compliance.


  • Open Access

    Four years of experience of minimally invasive treatment of benign thyroid nodule

    by Viktor Gennad'Evich Petrov, Alsu Asatovna Nelaeva, Elena Valer'Evna Antonova, Ekaterina Vladimirovna Molozhavenko, Irina Al'Tafovna Khuchasheva, Evgeniy Vladimirovich Melekhin

    With the use of minimally invasive techniques (MIM) treated 489 patients with cystic-colloid nodes. Laser-induced thermotherapy (LITT) — 371 patient, Ethanol destruction of ED — 54 patients, 63 — combined technique (KombiLITT). Dynamics of node size was assessed in 356 patients (72.8%). LITT — 252 patients, ED — 50 patients KombiLITT — 52 patients. LITT used in the treatment of solid structure nodes. Additional nodes up to 1 cm3 after LITT large part diminished by more than 50% (43 of 76). Additional nodes 1—2 cm3 also decreased more than half by more than 50% (39 of 67). Among nodules greater than 4 cm3 was not a single site that would reduce in volume by more than 75%. However, most of them decreased by more than 25%. The algorithm of differential treatment of cystic nodes. ED performed in 54 patients with cystic destruction of a site more than 70%. Marked decrease in the average volume at 4.68 ± 2.25 cm3 to 1.15 ± 0.9 cm3. KombiLITT performed in 63 patients with cystic cavity 20 to 70%. Volume units decreased at 7.98 ± 4.56 cm3 to 1.87 ± 0.9 cm3. LITT performed in 30 patients with major nodes and cystic cavities less than 20% of the site. Marked decrease in the volume of units at 2.89 ± 1.25 cm3 and 1.42 ± 0.8 cm3. LITT held 31 patients with small cystic nodes to 1 cm3. Marked decrease in size at 0.69 ± 0.23 cm3 to 0.29 ± 0.12 cm3. It has been shown that changes in thyroid status after MIM operations does not occur.

  • Open Access

    Criteria of immobilization duration of the affected foot in diabetic Charcot neuro-osteoarthropathy

    by Anastasia Gennad'Evna Demina, Vadim Borisovich Bregovskiy, Irina Al'Bertovna Karpova

    Длительная разгрузка является основным методом лечения острой стадии артропатии Шарко. Предполагается, что показания к прекращению иммобилизации и переходу к ходьбе должны быть основаны на клинических признаках прекращения воспаления и данных объективных методов. Однако в современной литературе отсутствует единое мнение о том, какие обследования и методы достаточны для определения завершения острой стадии и перевода больного от иммобилизации к ходьбе. В работе обсуждаются клинические методы оценки активности артропатии и специальные исследования, применяемые для этой цели, их достоинства и недостатки.


  • Open Access

    Programma skrininga sakharnogo diabeta 2 tipa v Sankt-Peterburge

    by Irina Al'Bertovna Karpova, Alsu Gafurovna Zalevskaya

    Программа скрининга сахарного диабета 2 типа в Санкт-Петербурге